Kavita V. Nair, PhD, is a professor in the Department of Neurology and the Center for Pharmaceutical Outcomes Research (CePOR) at the University of Colorado Anschutz Medical Campus. Over the last decade her primary research interests lie in evaluating the treatment of neurological diseases. Primarily in examining the comparative effectiveness of disease modifying agents used in the management of multiple sclerosis using a combination of several measures to include brain atrophy measurement, clinical cognition, blood biomarkers and patient reported outcomes. Dr Nair leads the Neurology Investigator Initiated Trials Team (NIITe) program in the Department of Neurology whose primary goal is to foster research relationships between neurology investigators and industry partners. Her other areas of interest involve improving access related issues and assessing the disruption in care for patients with neurological conditions taking infusible agents. She also serves as the Vice Chair of the Coding and Payment Policy Subcommittee and a member of the Health Services Research Subcommittee at the American Academy of Neurology.